Cargando…
The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment
Chronic liver disease (CLD) is frequently seen in the hemophilia population. The ADVANCE Working Group conducted a cross-sectional study in which people with hemophilia (PWH) aged ≥40 years were included. This study aimed to assess the associations between CLD and its risk factors using data from th...
Autores principales: | Qvigstad, Christian, Tait, Robert Campbell, Rauchensteiner, Stephan, Berntorp, Erik, de Moerloose, Philippe, Schutgens, Roger E., Holme, Pål Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181599/ https://www.ncbi.nlm.nih.gov/pubmed/30278553 http://dx.doi.org/10.1097/MD.0000000000012551 |
Ejemplares similares
-
Hematuria in aging men with hemophilia: Association with factor prophylaxis
por: Qvigstad, Christian, et al.
Publicado: (2020) -
Macroscopic hematuria as a risk factor for hypertension in ageing people with hemophilia and a family history of hypertension
por: Qvigstad, Christian, et al.
Publicado: (2020) -
Gene Therapy in Hemophilia: From Hype to Hope
por: Schutgens, Roger
Publicado: (2018) -
Gene Therapy for Hemophilia A: How Long Will It Last?
por: Schutgens, Roger E. G.
Publicado: (2022) -
The effect of emicizumab and bypassing agents in patients with hemophilia – An in vitro study
por: Schultz, Nina Haagenrud, et al.
Publicado: (2021)